By John D. England, MD
John D. England, MD
The COVID-19 pandemic has created an unprecedented medical, social, and economic crisis. Although the respiratory system is the major site of infection with SARS-CoV-2, many other complications are now recognized. Although not initially suspected, neurological features of COVID-19 do occur. In fact, for patients who recover from the respiratory disease, neurological complications may be one of the severe lasting features of COVID-19. New information on COVID-19 becomes available very quickly, often on a daily basis.
To facilitate rapid dissemination of new results and observations on COVID-19, the Journal of the Neurological Sciences and its companion journal, eNeurologicalSci have agreed to review rapidly all manuscripts relevant to COVID-19 and to publish expeditiously all accepted papers. Additionally, all such articles are freely available
upon publication. To facilitate ease of access to COVID-19 articles and guidelines, Elsevier and the World Federation of Neurology have both developed new platforms specific to COVID-19. These sites are refreshed regularly as new research, guidelines, and commentary become available.
If you are interested in learning what articles and resources are available, please access the following sites: COVID-19 Health care Hub (covid-19.elsevier.health) and World Federation of Neurology. •
John D. England, MD, is editor-in-chief of the Journal of the Neurological Sciences, the official journal of the WFN.
